Cash
Portfolio
TrendingMidtermsElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive229AccountSocial
MARKETSINVESTLIVE229
Product
Kalshi ProInvestMarketsIncentive programInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatoryTrust Center
© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
Series Image
  1. Medicine

Will the FDA approve MDMA for PTSD?

4
Chance
Before Jan 1, 2029
49%

Before Jan 1, 2029

49%
Before Jan 1, 2030
50%

Before Jan 1, 2030

50%
Before Jan 1, 2032
51%

Before Jan 1, 2032

51%
3 more
Will the FDA approve MDMA for PTSD?

Before Jan 1, 2027

Odds
14% chance
Max payout
Dec 31, 2026
$0
$13,668 vol
More Science and Technology Markets

More Will the FDA approve drug? markets

Will the FDA approve cytisinicline for smoking cessation?Will the FDA approve CagriSema?Will the FDA approve intismeran autogene (V940/mRNA-4157)?

Trending Science and Technology markets

Best AI at the end of 2026?Will the U.S. confirm that aliens exist?How many launches will SpaceX have in November?Where will Waymo operate this year?When will Anthropic release Mythos?When will OpenAI release Astra 6.1?Will a pneumonic plague case be reported in the U.S. this year?Tesla Optimus released this year?

Science and Technology hub

All Science and Technology markets